Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
2. 9-cis-tretinoin Tocoferil
3. Tretinoin Tocoferil
1. Tretinoin Tocoferil
2. 40516-48-1
3. Tocopheryl Retinoate
4. Tretinoin Tocoferil [inn]
5. 40516-49-2
6. Tretinoin Tocoferil (jan)
7. Dl-alpha-tocopherylretinoate
8. D-alpha-tocopheryl Retinoate
9. 0wn694nbmm
10. Ctd060b1ss
11. Ncgc00181354-01
12. Dl-alpha-tocopheryl Retinoate
13. [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
14. Chebi:32240
15. L300
16. Olcenon
17. Tretinoin Tocoferil [jan]
18. Toco-retinoate
19. Ac1nqzmb
20. Alpha-tocopheryl Retinoate
21. Unii-0wn694nbmm
22. Unii-ctd060b1ss
23. Tocorretinate
24. L-300
25. N-021
26. Tocoretinate [mi]
27. Tocoretinate [jan]
28. Dsstox_cid_26923
29. Dsstox_rid_82019
30. Dsstox_gsid_46923
31. Schembl668391
32. Chembl262520
33. Dtxsid6046923
34. Tocopheryl Retinoate [inci]
35. Zinc3929609
36. .alpha.-tocopheryl Retinoate
37. Tox21_112812
38. Ac-790
39. Tretinoin Tocoferil [who-dd]
40. Akos015961939
41. D-.alpha.-tocopherol Retinoate
42. D-.alpha.-tocopheryl Retinoate
43. [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]chroman-6-yl] (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
44. N021
45. Cas-40516-48-1
46. D01516
47. 516t481
48. Retinoic Acid .alpha.-tocopheryl Ester [mi]
49. Q27114835
50. (+-)-(2r*)-2,5,7,8-tetramethyl-2-((4r*,8r*)-4,8,12-trimethyltridecyl)-6-chromanyl Retinoate
51. (+/-)-(2r*)-2,5,7,8-tetramethyl-2-((4r*,8r*)-4,8,12-trimethyltridecyl)-6-chromanyl Retinoate
52. (2e,4e,6e,8e)-((r)-2,5,7,8-tetramethyl-2-((4r,8r)-4,8,12-trimethyltridecyl)chroman-6-yl) 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate
53. (2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydro-2h-1-benzopyran-6-ol Retinoate
54. Retinoic Acid, (2r)-3,4-dihydro-2,5,7,8-tetramethyl-2-((4r,8r)-4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl Ester
55. Retinoic Acid, (2r)-3,4-dihydro-2,5,7,8-tetramethyl-2-((4r,8r)-4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl Ester, (+/-)-
56. Retinoic Acid, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl Ester, (2r*(4r*,8r*))-(+/-)-
57. Retinoic Acid, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl Ester, (2r-(2r*(4r*,8r*)))-
| Molecular Weight | 713.1 g/mol |
|---|---|
| Molecular Formula | C49H76O3 |
| XLogP3 | 16.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 19 |
| Exact Mass | 712.57944628 g/mol |
| Monoisotopic Mass | 712.57944628 g/mol |
| Topological Polar Surface Area | 35.5 Ų |
| Heavy Atom Count | 52 |
| Formal Charge | 0 |
| Complexity | 1280 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 4 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Tocoretinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tocoretinate, including repackagers and relabelers. The FDA regulates Tocoretinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tocoretinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tocoretinate supplier is an individual or a company that provides Tocoretinate active pharmaceutical ingredient (API) or Tocoretinate finished formulations upon request. The Tocoretinate suppliers may include Tocoretinate API manufacturers, exporters, distributors and traders.
click here to find a list of Tocoretinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tocoretinate Drug Master File in Japan (Tocoretinate JDMF) empowers Tocoretinate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tocoretinate JDMF during the approval evaluation for pharmaceutical products. At the time of Tocoretinate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tocoretinate suppliers with JDMF on PharmaCompass.
Tocoretinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tocoretinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tocoretinate GMP manufacturer or Tocoretinate GMP API supplier for your needs.
A Tocoretinate CoA (Certificate of Analysis) is a formal document that attests to Tocoretinate's compliance with Tocoretinate specifications and serves as a tool for batch-level quality control.
Tocoretinate CoA mostly includes findings from lab analyses of a specific batch. For each Tocoretinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tocoretinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tocoretinate EP), Tocoretinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tocoretinate USP).
LOOKING FOR A SUPPLIER?
